## FCX: Freeport-McMoRan Inc. - XLB: Basic Materials

### Executive Summary

STRENGTH thesis confirmed: MRS_10 at 3.8% in lower entry zone (3.0-6.0%), top quartile (84th pct) cross-sectional ranking. Short-term MRS_5 (1.8%) confirms momentum alignment. Momentum building (+1.0% 5-day). Outperforming sector by 4.3%.

- **Horizon:** 5-20 days (swing)
- **Risk Profile:** Moderate - momentum continuation
- **Stop Type:** Fixed 2xATR ($41.59)
- **If Wrong:** Exit if MRS_10 drops below entry zone or breaks stop
- **Invalidation:** MRS_10 exits entry zone or MRS_5 turns negative

### News

- **Articles:** 10
- **Sentiment:** Bearish (Bullish: 1, Bearish: 6)

**1. FCX Stockholders Have Opportunity to Lead Freeport-McMoRan Inc. Class Action Lawsuit â€“ Contact Bronstein, Gewirtz and Grossman, LLC Today!**
- Source: KFOR | 20251204T210758 | Bearish | Relevance: 100%
- Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Freeport-McMoRan Inc. (NYSE: FCX) for alleged violations of federal securities laws. The lawsuit claims that Freeport made false or misleading statements regarding safety at its Grasberg Block Cave mine, leading to undisclosed risks and investor damages. Investors who purchased Freeport securities between February 15, 2022, and September 24, 2025, are encouraged to contact the law firm to learn about their opportunity to participate as lead plaintiff by January 12, 2026.

**2. Copper giant Freeport's CEO won't count on mergers for growth**
- Source: Reuters | 20251204T155014 | Bullish | Relevance: 100%
- Freeport-McMoRan CEO Kathleen Quirk stated that while the company is open to merger and acquisition opportunities, it is not relying on them for growth. Instead, Freeport expects to achieve up to 50% growth in its U.S. business over the next five years through internal organic growth initiatives. Quirk made these remarks at the Reuters NEXT conference in New York.

**3. Portnoy Law Firm Announces Class Action on Behalf of Freeport-McMoran, Inc. Investors**
- Source: GlobeNewswire | 20251204T150848 | Bearish | Relevance: 100%
- The Portnoy Law Firm is advising Freeport-McMoran, Inc. (NYSE: FCX) investors of a class action lawsuit for those who purchased securities between February 15, 2022, and September 24, 2025. This action stems from a suspension of mining activities at the Grasberg Block Cave operation in Indonesia, which led to significant drops in Freeport's stock price following reports of trapped workers, and subsequently, fatalities and missing personnel. Investors have until January 12, 2026, to file a lead plaintiff motion.

**4. Portnoy Law Firm Announces Class Action on Behalf of Freeport-McMoran, Inc. Investors**
- Source: GlobeNewswire | 20251204T150315 | Bearish | Relevance: 100%
- The Portnoy Law Firm has announced a class action lawsuit on behalf of investors in Freeport-McMoran, Inc. who purchased securities between February 15, 2022, and September 24, 2025. This action follows significant stock price drops after the company suspended mining operations at its Grasberg Block Cave due to an incident that resulted in fatalities and missing workers. Investors have until January 12, 2026, to file a lead plaintiff motion.

**5. XTX Topco Ltd Trims Position in Freeport-McMoRan Inc. $FCX**
- Source: MarketBeat | 20251204T131758 | Somewhat-Bullish | Relevance: 100%
- XTX Topco Ltd significantly reduced its stake in Freeport-McMoRan Inc. by 83.6% in the second quarter, selling over 80,000 shares. Despite this, Freeport-McMoRan reported strong earnings, exceeding consensus estimates in its last quarter. The company also pays a quarterly dividend and holds a consensus "Buy" rating from analysts with an average target price of $46.73.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 0, Lowers: 3)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-19 | Morgan Stanley | $44 | $46 | -4% |
| 2025-11-19 | BMO Capital | $47 | $48 | -2% |
| 2025-11-19 | Scotiabank | $47 | $51 | -8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-19 | Morgan Stanley | main | Overweight |
| 2025-11-19 | BMO Capital | main | Outperform |
| 2025-11-19 | Scotiabank | up | Sector Outperform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 2 ($0.05M) |
| Sells | 3 ($1.82M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 39.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 9.0% (+1.4%)
- Blackrock Inc.: 7.4% (+0.6%)
- Fisher Asset Managem: 4.4% (+1.4%)
- State Street Corpora: 4.3% (+1.1%)
- Capital Research Glo: 2.9% (-31.2%)

### Key Risks

1. Valuation risk: PEG 4.5x with declining EPS estimates leaves no margin for error.
2. Market regime shift could impact momentum names disproportionately.
3. Sector rotation risk if leadership changes from current market theme.

### Catalysts

- Broader market risk-on sentiment could lift quality names.
- Year-end positioning and window dressing may support price.

### Fundamentals

PEG ratio 4.54 signals overvaluation risk, limited margin of safety. Forward P/E 19.5x attractive for 49% earnings growth. Balance sheet: strong liquidity (2.5x). Analyst sentiment negative (3 target cuts vs 0 raises). Insider selling cluster ($1.8M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $76.2B |
| Beta | 1.48 |
| 52W Range | $27.66 - $53.77 |
| Short Interest | 2.0% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.54 |
| Forward P/E | 19.5 |
| Current P/E | 29.0 |
| YoY Growth | 49.3% |
| EPS Direction | FALLING |

### Technicals

MRS_10 improving modestly (+1.0% over 5 days). Currently in lower STRENGTH zone (3.0-6.0%), cross-sectional ranking at 84th percentile. MRS_5 at 1.8% confirms short-term momentum alignment. Outperforming sector by 4.3pp, stock-specific strength. Full SMA alignment bullish (above 20/50/200 SMAs). OFD pattern: +MLN (Support).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 3.77% (CS: 84) | Strong |
| RSI_14 | 64.8 | Neutral |
| MACD Histogram | 0.50 | Bullish |
| vs SMA20 | 1.082x | Above |
| vs SMA50 | 1.092x | Above |
| vs SMA200 | 1.102x | Above |

### Decision

- **Verdict:** BUY
- **Thesis:** STRENGTH

### Trade Setup

- **Entry:** $44.61
- **Stop Loss:** $41.59 (6.8% risk)
- **Target:** $49.14 (R:R method)
- **Risk/Reward:** 1.50:1
- **Target Reasoning:** STRENGTH thesis targets 1.5x risk/reward based on historical edge

### Position Sizing

- **Shares:** 165
- **Position Value:** $7,360.65
- **Portfolio %:** 7.36%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

*NORMAL regime with moderate risk appetite and mixed signals. VIX at 15.78 indicates calm conditions but breadth at 53% suggests narrow participation. Fed policy remains neutral with 42 days to next meeting, supporting steady positioning with sector selectivity.*

### Earnings

**Next:** 2026-01-22 (Est: $0.24)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.41 | $0.50 | +22.8% |
| 2025Q2 | $0.44 | $0.54 | +21.8% |
| 2025Q1 | $0.23 | $0.24 | +4.6% |
| 2024Q4 | $0.22 | $0.31 | +43.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*